IceCure Medical Ltd. (ICCM) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for IceCure Medical Ltd. (ICCM:NASDAQ), powered by AI.

Current Price
$2.13
Sector
Healthcare
What is the IceCure Medical Ltd. stock price forecast?

IceCure Medical Ltd. is currently trading at $2.13. View real-time AI analysis on Alpha Lenz.

What is IceCure Medical Ltd. insider trading activity?

View the latest insider trading data for IceCure Medical Ltd. on Alpha Lenz.

What is IceCure Medical Ltd.'s P/E ratio?

View IceCure Medical Ltd.'s valuation metrics on Alpha Lenz.

IceCure Medical Ltd.

NASDAQ · ICCM
$2.13-0.05(-2.29%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about IceCure Medical Ltd.'s future dividend policy...
Alpha Chat Insight

IceCure Medical Ltd.'s ROE is -188.8%. Explore profitability and growth together.

Ask for details

Company Overview

IceCure Medical Ltd. is a pioneering company in the medical equipment industry, specializing in innovative cryoablation technology. The primary focus of IceCure's product offerings is the minimally invasive treatment of cancerous tumors through extreme cold, a procedure known as cryoablation. This technology provides an alternative to traditional surgical methods, promoting faster recovery and reduced risk for patients. IceCure's solutions are particularly significant in the treatment of breast, kidney, lung, bone, and liver cancers, offering oncologists a versatile tool in precision medicine. Based in Israel, IceCure Medical Ltd. plays a crucial role in the medical technology market by continuously advancing its devices to enhance efficacy and safety. The company's innovations are particularly significant in healthcare markets striving for less invasive treatment options that maintain high standards of patient care. With a growing footprint in global healthcare, IceCure Medical Ltd. collaborates with medical professionals to expand its reach and impact in the fight against cancer. As such, IceCure Medical Ltd. stands out in the medical device sector as a leader in cryogenic solutions for oncology.

CEOMr. Eyal Shamir
SectorHealthcare
IndustryMedical Devices
Employees64

Company Statistics

FY 2025

Profile

N/AMarket Cap
$3.38MRevenue
0.00Shares Out
64Employees

Margins

36.28%Gross
-437.97%EBITDA
-446.70%Operating
-445.61%Pre-Tax
-445.61%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

3.08%Rev 3Yr
25.43%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-113.79%ROA
-188.78%ROE
-114.07%ROIC

Financial Health

$8.90MCash & Cash Equivalents
$-4.06MNet Debt
53.44%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

IceCure Medical Ltd. (ticker: ICCM) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 64 employees.

The current price is $2.13 with a P/E ratio of -x and P/B of -x.

ROE is -188.78% and operating margin is -446.70%. Annual revenue is $3M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
IceCure Medical Ltd. (ICCM) Stock Forecast 2026 $2.13 — Price, Financials & Analyst Targets | Alpha Lenz